Vertex Pharmaceuticals Ownership | Who Owns Vertex Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Vertex Pharmaceuticals Ownership Summary


Vertex Pharmaceuticals is owned by 82.46% institutional investors, 0.21% insiders, and 17.34% retail investors. Capital world investors is the largest institutional shareholder, holding 10.28% of VRTX shares. American Funds Growth Fund of Amer A is the top mutual fund, with 5.48% of its assets in Vertex Pharmaceuticals shares.

VRTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVertex Pharmaceuticals82.46%0.21%17.34%
SectorHealthcare Stocks 35.56%12.08%52.36%
IndustryBiotech Stocks 35.43%12.01%52.56%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Capital world investors26.12M10.28%$12.97B
Blackrock funding, inc. /de24.11M9.49%$11.98B
Vanguard group24.11M9.43%$10.93B
Blackrock21.31M8.25%$9.99B
Capital research global investors19.49M7.67%$9.68B
State street11.87M4.67%$5.90B
Jpmorgan chase6.52M2.56%$3.26B
Geode capital management6.02M2.37%$2.98B
Capital investors4.70M1.85%$2.33B
Loomis sayles & co l p4.00M1.57%$1.79B

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Kynam capital management, lp330.00K11.93%$154.68M
Bellevue group681.91K7.25%$304.50M
Provident investment management140.73K6.79%$69.90M
Andrew hill investment advisors13.23K4.88%$6.57M
Motley fool wealth management636.004.80%$316.10K
Bridger management18.78K3.96%$7.35M
Superstring capital management lp11.01K3.51%$4.92M
Artia global partners lp55.10K3.42%$21.58M
Sivik global healthcare10.00K3.39%$4.46M
Mcrae capital management33.19K3.24%$16.49M

Top Buyers

HolderShares% AssetsChange
Norges bank2.97M0.15%2.97M
Vanguard fiduciary trust1.47M0.17%1.47M
Capital world investors26.12M1.53%746.89K
Goldman sachs group2.42M0.12%663.76K
Vanguard global advisers555.73K0.13%555.73K

Top Sellers

HolderShares% AssetsChange
Parnassus investments---1.65M
Capital research global investors19.49M1.35%-1.64M
Winslow capital management---887.64K
Artisan partners limited partnership---650.26K
Blackrock21.31M0.23%-648.44K

New Positions

HolderShares% AssetsChangeValue
Norges bank2.97M0.15%2.97M$1.48B
Vanguard fiduciary trust1.47M0.17%1.47M$654.50M
Vanguard global advisers555.73K0.13%555.73K$248.16M
Vanguard asset management442.18K0.17%442.18K$197.45M
Lord, abbett166.51K0.24%166.51K$74.35M

Sold Out

HolderChange
Mcclarren financial advisors-1.00
Ruedi wealth management-1.00
Mine & arao wealth creation & management, llc.-1.00
Strategic advocates-1.00
Cgc financial services-1.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20261,587-7.84%210,840,715-10.55%820.97%765-12.97%538-6.43%
Dec 31, 2025806-48.63%44,328,589-80.90%170.21%410-40.58%269-56.19%
Sep 30, 2025865-46.24%59,581,660-75.23%230.26%362-50.82%356-41.54%
Jun 30, 20251,575-5.06%240,147,0121.70%931.11%716-14.86%5994.90%
Mar 31, 20251,6401.74%235,693,425-0.06%911.09%82911.42%567-7.35%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds Growth Fund of Amer A13.93M5.48%950.21K
Capital Group Growth Fnd of Amer Comp12.54M4.94%-1.39M
American Funds Growth Fd of Amer A12.54M4.94%-1.39M
Vanguard US Total Market Shares ETF8.18M3.19%16.09K
Vanguard Morn Total Stk Mkt Idx Investor8.06M3.18%-26.52K
Vanguard Total Stock Mkt Idx Inv8.06M3.18%-26.52K
Vanguard Institutional 500 Index Trust7.30M2.84%51.91K
Vanguard 500 Index Investor6.59M2.60%-57.96K
Capital Group Investment Co of Amer Comp6.27M2.47%-
American Funds Invmt Co of Amer A6.27M2.47%-

Recent Insider Transactions


DateNameRoleActivityValue
Jul 02, 2026Tatsis Ourania EVP, Chief Reg. & Quality Off.Sell$787.49K
Jul 02, 2026McKechnie Duncan EVP, Chief Commercial OfficerSell$799.78K
Jul 01, 2026Liu Joy EVP and Chief Legal OfficerSell$416.24K
Jun 26, 2026Bozic Carmen EVP and CMOSell$287.57K
Jun 18, 2026Bozic Carmen EVP and CMOSell$471.41K

Insider Transactions Trends


DateBuySell
2026 Q3-3
2026 Q2-11
2026 Q1-56
2025 Q4-23
2025 Q341

VRTX Ownership FAQ


Who Owns Vertex Pharmaceuticals?

Vertex Pharmaceuticals shareholders are primarily institutional investors at 82.46%, followed by 0.21% insiders and 17.33% retail investors. The average institutional ownership in Vertex Pharmaceuticals's industry, Biotech Stocks , is 35.43%, which Vertex Pharmaceuticals exceeds.

Who owns the most shares of Vertex Pharmaceuticals?

Vertex Pharmaceuticals’s largest shareholders are Capital world investors (26.12M shares, 10.28%), Blackrock funding, inc. /de (24.11M shares, 9.49%), and Vanguard group (24.11M shares, 9.43%). Together, they hold 29.20% of Vertex Pharmaceuticals’s total shares outstanding.

Does Blackrock own Vertex Pharmaceuticals?

Yes, BlackRock owns 8.25% of Vertex Pharmaceuticals, totaling 21.31M shares as of Jun 2024. This represents 0.23% of BlackRock's total assets, with a market value of 9.99B$. In the last quarter, BlackRock decreased its holdings by -648K shares, a -2.95% change.

Who is Vertex Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Kynam capital management, lp is Vertex Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 11.93% of its assets in 330K Vertex Pharmaceuticals shares, valued at 154.68M$.

Who is the top mutual fund holder of Vertex Pharmaceuticals shares?

American Funds Growth Fund of Amer A is the top mutual fund holder of Vertex Pharmaceuticals shares, with 5.48% of its total shares outstanding invested in 13.93M Vertex Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools